Singapore markets closed
Straits Times Index
3,299.46 -3.73 (-0.11%) S&P 500
5,180.74 +52.95 (+1.03%) Dow
38,852.27 +176.59 (+0.46%) Nasdaq
16,349.25 +192.92 (+1.19%) Bitcoin USD
64,258.79 -1,068.75 (-1.64%) CMC Crypto 200
1,331.67 -33.46 (-2.45%)
Chugai Pharmaceutical Co., Ltd. (4519.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 5,094.00 |
| Open | 5,145.00 |
| Bid | 4,968.00 x 0 |
| Ask | 4,985.00 x 0 |
| Day's range | 4,943.00 - 5,148.00 |
| 52-week range | 3,522.00 - 6,697.00 |
| Volume | |
| Avg. volume | 2,531,673 |
| Market cap | 8.202T |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 25.16 |
| EPS (TTM) | 198.16 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 82.00 (1.61%) |
| Ex-dividend date | 27 Jun 2024 |
| 1y target est | 6,181.80 |
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's Why
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.